Literature DB >> 24374407

Epileptic seizures in diffuse low-grade gliomas in adults.

Johan Pallud1, Etienne Audureau, Marie Blonski, Nader Sanai, Luc Bauchet, Denys Fontaine, Emmanuel Mandonnet, Edouard Dezamis, Dimitri Psimaras, Jacques Guyotat, Philippe Peruzzi, Philippe Page, Beatriz Gal, Eduardo Párraga, Marie-Hélène Baron, Michaela Vlaicu, Rémy Guillevin, Bertrand Devaux, Hugues Duffau, Luc Taillandier, Laurent Capelle, Gilles Huberfeld.   

Abstract

Diffuse low-grade gliomas are highly epileptogenic brain tumours. We aimed to explore the natural course of epileptic seizures, their predictors and the prognostic significance of their occurrence in adult patients harbouring a diffuse low-grade glioma. An observational retrospective multicentre study examined 1509 patients with diffuse low-grade gliomas to identify mutual interactions between tumour characteristics, tumour course and epileptic seizures. At diagnosis, 89.9% of patients had epileptic seizures. Male gender (P = 0.003) and tumour location within functional areas (P = 0.001) were independent predictors of a history of epileptic seizures at diagnosis. Tumour volume, growth velocity, cortical location, histopathological subtype or molecular markers did not significantly affect epileptic seizure occurrence probability. Prolonged history of epileptic seizures (P < 0.001), insular location (P = 0.003) and tumour location close to functional areas (P = 0.038) were independent predictors of uncontrolled epileptic seizures at diagnosis. Occurrence of epileptic seizures (P < 0.001), parietal (P = 0.029) and insular (P = 0.002) locations were independent predictors of uncontrolled epileptic seizures after oncological treatment. Patient age (P < 0.001), subtotal (P = 0.007) and total (P < 0.001) resections were independent predictors of total epileptic seizure control after oncological treatment. History of epileptic seizures at diagnosis and total surgical resection were independently associated with increased malignant progression-free (P < 0.001 and P < 0.001) and overall (P < 0.001 and P = 0.016) survivals. Epileptic seizures are independently associated with diffuse low-grade glioma prognosis. Patients diagnosed with epileptic seizures and those with complete and early surgical resections have better oncological outcomes. Early and maximal surgical resection is thus required for diffuse low-grade gliomas, both for oncological and epileptological purposes.

Entities:  

Keywords:  diffuse low-grade gliomas; epileptic seizures; predictors; prognosis; surgery

Mesh:

Year:  2013        PMID: 24374407     DOI: 10.1093/brain/awt345

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  84 in total

Review 1.  Tumor-related epilepsy: epidemiology, pathogenesis and management.

Authors:  Dillon Y Chen; Clark C Chen; John R Crawford; Sonya G Wang
Journal:  J Neurooncol       Date:  2018-05-24       Impact factor: 4.130

Review 2.  Surgery of insular and paralimbic diffuse low-grade gliomas: technical considerations.

Authors:  Karine Michaud; Hugues Duffau
Journal:  J Neurooncol       Date:  2016-05-09       Impact factor: 4.130

3.  Do not omit the grade of malignancy when correlating the lobar location of diffuse gliomas and the risk of preoperative epileptic seizures.

Authors:  Johan Pallud; Marc Zanello; Alexandre Roux
Journal:  Neurosurg Rev       Date:  2018-10-11       Impact factor: 3.042

4.  Current Management of Adult Diffuse Infiltrative Low Grade Gliomas.

Authors:  Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

5.  Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.

Authors:  Andrés F Cardona; Leonardo Rojas; Beatriz Wills; Laura Bernal; Alejandro Ruiz-Patiño; Oscar Arrieta; Enrique Jiménez Hakim; Fernando Hakim; Juan Armando Mejía; Nicolás Useche; Sonia Bermúdez; Hernán Carranza; Carlos Vargas; Jorge Otero; Luis Carlos Mayor; León Darío Ortíz; Sandra Franco; Carlos Ortíz; Miguel Gil-Gil; Carmen Balaña; Zyanya Lucia Zatarain-Barrón
Journal:  J Neurooncol       Date:  2017-11-25       Impact factor: 4.130

Review 6.  Seizures in oligodendroglial tumors.

Authors:  Melissa Kerkhof; Christa Benit; Alberto Duran-Pena; Charles J Vecht
Journal:  CNS Oncol       Date:  2015-10-19

Review 7.  New concepts in the management of diffuse low-grade glioma: Proposal of a multistage and individualized therapeutic approach.

Authors:  Hugues Duffau; Luc Taillandier
Journal:  Neuro Oncol       Date:  2014-08-02       Impact factor: 12.300

8.  A better surgical resectability of WHO grade II gliomas is independent of favorable molecular markers.

Authors:  Dominik Cordier; Catherine Gozé; Sabine Schädelin; Valérie Rigau; Luigi Mariani; Hugues Duffau
Journal:  J Neurooncol       Date:  2014-09-28       Impact factor: 4.130

9.  What is New in the Management of Epilepsy in Gliomas?

Authors:  Roberta Rudà; Riccardo Soffietti
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

Review 10.  Incidental diffuse low-grade gliomas: from early detection to preventive neuro-oncological surgery.

Authors:  Guilherme Lucas de Oliveira Lima; Marc Zanello; Emmanuel Mandonnet; Luc Taillandier; Johan Pallud; Hugues Duffau
Journal:  Neurosurg Rev       Date:  2015-11-27       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.